Topical tretinoin therapy and all-cause mortality

Archives of Dermatology

Volumn 145, Issue 1, 2009, Pages 18-24

  Weinstock, Martin A ^a,i   Bingham, Stephen F ^b   Lew, Robert A ^b   Hall, Russell ^c   Eilers, David ^b   Kirsner, Robert ^d   Naylor, Mark ^e   Kalivas, James ^f   Cole, Gary ^g   Marcolivio, Kimberly ^a   Collins, Joseph ^b   DiGiovanna, John J ^a   Vertrees, Julia E ^h  

^a BROWN UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MIAMI   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f CARL T HAYDEN VA MEDICAL CENTER   (United States)

^g VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^h University of New Mexico   (United States)

ⁱ PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RETINOIC ACID;

AGE DISTRIBUTION; AGED; ARTERIOSCLEROSIS; ARTICLE; ATHEROSCLEROSIS; BLOOD DISEASE; CANCER MORTALITY; CANCER RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CHEMOPROPHYLAXIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DISEASE ASSOCIATION; DROWNING; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG FATALITY; EAR; EMPHYSEMA; FACE; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HEART INFARCTION; HEPATOBILIARY DISEASE; HUMAN; IMMUNOPATHOLOGY; INFECTION; INFESTATION; INJURY; INTOXICATION; KERATINOCYTE CARCINOMA; KIDNEY DISEASE; LUNG SMALL CELL CANCER; LYMPHATIC SYSTEM DISEASE; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM DISEASE; MENTAL DISEASE; METABOLIC DISORDER; NUTRITIONAL DISORDER; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PREDICTION; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; RISK REDUCTION; SKIN CARCINOMA; SMOKING; STATISTICAL SIGNIFICANCE; SUICIDE; THORAX DISEASE; TOPICAL TREATMENT; TREATMENT FAILURE; TREATMENT OUTCOME; VETERAN; WITHDRAWAL SYNDROME;

ADMINISTRATION, TOPICAL; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CAUSE OF DEATH; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; SKIN NEOPLASMS; TRETINOIN;

EID: 58849132286     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2008.542     Document Type: Article

References (25)

1. Kraemer KH, DiGiovanna JJ, Moshell AN, Tarone RE, Peck GL. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med. 1988;318(25):1633-1637.
2. Bavinck JN, Tieben LM, Van der Woude FJ, et al. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients. J Clin Oncol. 1995;13(8):1933-1938.
3. Harwood CA, Leedham-Green M, Leigh IM, Proby CM. Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study. Arch Dermatol. 2005;141(4):456-464.
4. Lippman SM, Lee JJ, Karp DD, et al. Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer. J Natl Cancer Inst. 2001;93(8):605-618.
5. Omenn GS. Chemoprevention of lung cancers. Eur J Cancer Prev. 2007;16(3):184-191.
6. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
7. Karagas MR, Stukel TA, Greenberg ER, Baron JA, Mott LA, Stern RS. Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. JAMA. 1992;267(24):3305-3310.
8. Grodstein F, Speizer FE, Hunter DJ. A prospective study of cutaneous squamous cell carcinoma of the skin in the Nurses' Health Study. J Natl Cancer Inst. 1995;87(14):1061-1066.
9. International Federation of Pharmaceutical Manufacturers and Associations. Medical Dictionary for Regulatory Activities (MedDRA). Chantilly, VA: Maintenance and Support Services Organization; 2003.
10. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996;334(18):1150-1155.
11. Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330(15):1029-1035.
12. Bardia A, Tleyjeh IM, Cerhan JR, et al. Efficacy of antioxidant supplementation in reducing primary cancer incidence and mortality: systematic review and meta-analysis. Mayo Clin Proc. 2008;83(1):23-34.
13. Thomson PI. Drug Information for the Health Care Professional. Vol 1. 23rd ed. Greenwood Village, CO: Thomson Micromedex; 2003:2649.
14. Latriano L, Tzimas G, Wong F, Wills RT. The percutaneous absorption of topically applied tretinoin and its effect on endogenous concentrations of tretinoin and its metabolites after single doses or long-term use. J Am Acad Dermatol. 1997;36(3, pt 2):S37-S46.
15. Franz T, Lehman P, Franz S. Topical use of retinoic acid gel is not teratogenic [abstract 12]. J Invest Dermatol. 1993;100(4):490.
16. Worobec SM, Wong FGA, Tolman EL, Abrams LS, Parker GR, Thorne EG. Percutaneous absorption of 3H-tretinoin in normal volunteers [abstract 257]. J Invest Dermatol. 1991;96(4):574.
17. van Hoogdalem EJ. Transdermal absorption of topical anti-acne agents in man. J Eur Acad Dermatol Venereol. 1998;11(suppl 1):S13-S19.
18. Nau H. Embryotoxicity and teratogenicity of topical retinoic acid. Skin Pharmacol. 1993;6(suppl 1):35-44.
19. Prescribing information for RENOVA. Revised January 2006. http://www.aboutrenova.com/prescribinginfo.asp. Accessed March 18, 2008.
20. Buchan P, Eckhoff C, Caron D, Nau H, Shroot B, Schaefer H. Repeated topical administration of all-trans-retinoic acid and plasma level of retinoic acids in humans. J Am Acad Dermatol. 1994;30(3):428-434.
21. Krautheim A, Gollnick H. Transdermal penetration of topical drugs used in the treatment of acne. Clin Pharmacokinet. 2003;42(14):1287-1304.
22. Tsimberidou A-M, Kantarjian H, Keating MJ, Estey E. Optimizing treatment for elderly patients with acute promyelocytic leukemia. Leuk Lymphoma. 2006;47(11):2282-2287.
23. Tallman MS, Andersen JW, Schiffer CA, et al. Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. Blood. 2000;95(1):90-95.
24. Larson RS, Tallman MS. Retinoic acid syndrome. Best Pract Res Clin Haematol. 2003;16(3):453-461.
25. Rosenberg EW, Skinner RB Jr. Topical retinoids. J Thorac Oncol. 2006;1(7):732.